119 related articles for article (PubMed ID: 20636634)
1. Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial.
Bersudsky Y; Applebaum J; Gaiduk Y; Sharony L; Mishory A; Podberezsky A; Agam G; Belmaker RH
Bipolar Disord; 2010 Jun; 12(4):376-82. PubMed ID: 20636634
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.
Weiser M; Levi L; Levine SZ; Bialer M; Shekh-Ahmad T; Matei V; Tiugan A; Cirjaliu D; Sava C; Sinita E; Zamora D; Davis JM
Bipolar Disord; 2017 Jun; 19(4):285-294. PubMed ID: 28605109
[TBL] [Abstract][Full Text] [Related]
3. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive treatment of acute mania: a clinical overview.
Sachs GS; Gardner-Schuster EE
Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
[TBL] [Abstract][Full Text] [Related]
6. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
7. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
[TBL] [Abstract][Full Text] [Related]
8. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
Smulevich AB; Khanna S; Eerdekens M; Karcher K; Kramer M; Grossman F
Eur Neuropsychopharmacol; 2005 Jan; 15(1):75-84. PubMed ID: 15572276
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
[TBL] [Abstract][Full Text] [Related]
13. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
14. Risperidone in the treatment of mania.
Tohen M; Zarate CA; Centorrino F; Hegarty JI; Froeschl M; Zarate SB
J Clin Psychiatry; 1996 Jun; 57(6):249-53. PubMed ID: 8666562
[TBL] [Abstract][Full Text] [Related]
15. Comparison between lithium and valproate in the treatment of acute mania.
Shafti SS; Shahveisi B
J Clin Psychopharmacol; 2008 Dec; 28(6):718-20. PubMed ID: 19011453
[No Abstract] [Full Text] [Related]
16. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
17. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial.
Behzadi AH; Omrani Z; Chalian M; Asadi S; Ghadiri M
Acta Psychiatr Scand; 2009 Dec; 120(6):441-5. PubMed ID: 19392814
[TBL] [Abstract][Full Text] [Related]
18. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
[TBL] [Abstract][Full Text] [Related]
19. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
20. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
